The FDA issued a June 10 warning letter to Innova Medical Group Inc. in connection with the company’s rapid antigen tests for the SARS-CoV-2 virus, an action that accompanies a class I recall and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results